Literature DB >> 28855265

The Role of BAFF System Molecules in Host Response to Pathogens.

Jiro Sakai1, Mustafa Akkoyunlu2.   

Abstract

The two ligands B cell-activating factor of the tumor necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) and the three receptors BAFF receptor (BAFF-R), transmembrane activator and calcium-modulating cyclophilin ligand interactor (TACI), and B cell maturation antigen (BCMA) are members of the "BAFF system molecules." BAFF system molecules are primarily involved in B cell homeostasis. The relevance of BAFF system molecules in host responses to microbial assaults has been investigated in clinical studies and in mice deficient for each of these molecules. Many microbial products modulate the expression of these molecules. Data from clinical studies suggest a correlation between increased expression levels of BAFF system molecules and elevated B cell responses. Depending on the pathogen, heightened B cell responses may strengthen the host response or promote susceptibility. Whereas pathogen-mediated increases in the expression levels of the ligands and/or the receptors appear to promote microbial clearance, certain pathogens have evolved to ablate B cell responses by suppressing the expression of TACI and/or BAFF-R on B cells. Other than its well-established role in B cell responses, the TACI-mediated activation of macrophages is also implicated in resistance to intracellular pathogens. An improved understanding of the role that BAFF system molecules play in infection may assist in devising novel strategies for vaccine development.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  APRIL; BAFF; BAFF-R; DNA vaccines; TACI; bacteria; host response; parasite; virus

Mesh:

Year:  2017        PMID: 28855265      PMCID: PMC5608883          DOI: 10.1128/CMR.00046-17

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  193 in total

1.  TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts.

Authors:  Claudia Bossen; Teresa G Cachero; Aubry Tardivel; Karine Ingold; Laure Willen; Max Dobles; Martin L Scott; Aris Maquelin; Elodie Belnoue; Claire-Anne Siegrist; Stéphane Chevrier; Hans Acha-Orbea; Helen Leung; Fabienne Mackay; Jürg Tschopp; Pascal Schneider
Journal:  Blood       Date:  2007-10-17       Impact factor: 22.113

2.  A role for BLyS in the activation of innate immune cells.

Authors:  Sook Kyung Chang; Bonnie K Arendt; Jaime R Darce; Xiaosheng Wu; Diane F Jelinek
Journal:  Blood       Date:  2006-07-06       Impact factor: 22.113

3.  Cell to Cell Interaction Can Activate Membrane-bound APRIL Which Are Expressed on Inflammatory Macrophages.

Authors:  Sang-Min Lee; Won-Jung Kim; Kyoungho Suk; Won-Ha Lee
Journal:  Immune Netw       Date:  2010-10-31       Impact factor: 6.303

4.  APRIL affects antibody responses and early leukocyte infiltration, but not influenza A viral control.

Authors:  Gijs Hardenberg; Koen van der Sluijs; Tom van der Poll; Jan Paul Medema
Journal:  Mol Immunol       Date:  2008-05-08       Impact factor: 4.407

5.  CD73 Inhibition Shifts Cardiac Macrophage Polarization toward a Microbicidal Phenotype and Ameliorates the Outcome of Experimental Chagas Cardiomyopathy.

Authors:  Nicolás Eric Ponce; Liliana Maria Sanmarco; Natalia Eberhardt; Mónica Cristina García; Héctor Walter Rivarola; Roxana Carolina Cano; Maria Pilar Aoki
Journal:  J Immunol       Date:  2016-06-22       Impact factor: 5.422

6.  The plasma concentration of the B cell activating factor is increased in children with acute malaria.

Authors:  Eunice Nduati; Agnes Gwela; Henry Karanja; Cleopatra Mugyenyi; Jean Langhorne; Kevin Marsh; Britta C Urban
Journal:  J Infect Dis       Date:  2011-09-15       Impact factor: 5.226

7.  BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth.

Authors:  P Schneider; F MacKay; V Steiner; K Hofmann; J L Bodmer; N Holler; C Ambrose; P Lawton; S Bixler; H Acha-Orbea; D Valmori; P Romero; C Werner-Favre; R H Zubler; J L Browning; J Tschopp
Journal:  J Exp Med       Date:  1999-06-07       Impact factor: 14.307

Review 8.  The early interaction of Leishmania with macrophages and dendritic cells and its influence on the host immune response.

Authors:  Dong Liu; Jude E Uzonna
Journal:  Front Cell Infect Microbiol       Date:  2012-06-12       Impact factor: 5.293

9.  APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth.

Authors:  M Hahne; T Kataoka; M Schröter; K Hofmann; M Irmler; J L Bodmer; P Schneider; T Bornand; N Holler; L E French; B Sordat; D Rimoldi; J Tschopp
Journal:  J Exp Med       Date:  1998-09-21       Impact factor: 14.307

10.  Local BLyS production by T follicular cells mediates retention of high affinity B cells during affinity maturation.

Authors:  Radhika Goenka; Andrew H Matthews; Bochao Zhang; Patrick J O'Neill; Jean L Scholz; Thi-Sau Migone; Warren J Leonard; William Stohl; Uri Hershberg; Michael P Cancro
Journal:  J Exp Med       Date:  2013-12-23       Impact factor: 14.307

View more
  32 in total

1.  Deceleration of glycometabolism impedes IgG-producing B-cell-mediated tumor elimination by targeting SATB1.

Authors:  Jiajing Liu; Yifan Li; Zhou Lu; Jie Gu; Yun Liang; Enyu Huang; Zhiming Wang; Hushan Zhang; Luman Wang; Dan Zhang; Hongxiu Yu; Ronghua Liu; Yiwei Chu
Journal:  Immunology       Date:  2018-10-10       Impact factor: 7.397

2.  Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups.

Authors:  Yong-Fei Wang; Yan Zhang; Zhiming Lin; Huoru Zhang; Ting-You Wang; Yujie Cao; David L Morris; Yujun Sheng; Xianyong Yin; Shi-Long Zhong; Xiaoqiong Gu; Yao Lei; Jing He; Qi Wu; Jiangshan Jane Shen; Jing Yang; Tai-Hing Lam; Jia-Huang Lin; Zhi-Ming Mai; Mengbiao Guo; Yuanjia Tang; Yanhui Chen; Qin Song; Bo Ban; Chi Chiu Mok; Yong Cui; Liangjing Lu; Nan Shen; Pak C Sham; Chak Sing Lau; David K Smith; Timothy J Vyse; Xuejun Zhang; Yu Lung Lau; Wanling Yang
Journal:  Nat Commun       Date:  2021-02-03       Impact factor: 14.919

3.  Update on B Cell Response in Periodontitis.

Authors:  Julien Demoersman; Jacques Olivier Pers
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

4.  Monitoring of Soluble Forms of BAFF System (BAFF, APRIL, sR-BAFF, sTACI and sBCMA) in Kidney Transplantation.

Authors:  Isabel Legaz; Manuel Muro; Rafael Alfaro; Santiago Llorente; Pedro Martinez; Víctor Jimenez-Coll; Helios Martínez-Banaclocha; José Antonio Galián; Carmen Botella; María Rosa Moya-Quiles; Jesús de la Peña-Moral; Alfredo Minguela
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2022-09-22       Impact factor: 3.831

5.  Pathogen-Specific Humoral Immunity and Infections in B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy Recipients with Multiple Myeloma.

Authors:  Srirama Josyula; Margot J Pont; Sayan Dasgupta; Xiaoling Song; Sushma Thomas; Gregory Pepper; Jacob Keane-Candib; Terry L Stevens-Ayers; Hans D Ochs; Michael J Boeckh; Stanley R Riddell; Andrew J Cowan; Elizabeth M Krantz; Damian J Green; Joshua A Hill
Journal:  Transplant Cell Ther       Date:  2022-03-11

Review 6.  The Extensive Regulation of MicroRNA in Immune Thrombocytopenia.

Authors:  Yuerong Zhao; Siyuan Cui; Yan Wang; Ruirong Xu
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

Review 7.  Germinal Center and Extrafollicular B Cell Responses in Vaccination, Immunity, and Autoimmunity.

Authors:  Rebecca A Elsner; Mark J Shlomchik
Journal:  Immunity       Date:  2020-12-15       Impact factor: 31.745

8.  B cell-activating factor modulates the factor VIII immune response in hemophilia A.

Authors:  Bhavya S Doshi; Jyoti Rana; Giancarlo Castaman; Mostafa A Shaheen; Radoslaw Kaczmarek; John Ss Butterfield; Shannon L Meeks; Cindy Leissinger; Moanaro Biswas; Valder R Arruda
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808

Review 9.  Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma.

Authors:  Alessandra Romano; Paola Storti; Valentina Marchica; Grazia Scandura; Laura Notarfranchi; Luisa Craviotto; Francesco Di Raimondo; Nicola Giuliani
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

10.  CTLA-4 Blockade, during HIV Virus-Like Particles Immunization, Alters HIV-Specific B-Cell Responses.

Authors:  Phoebe E Lewis; Ethan C Poteet; Dongliang Liu; Changyi Chen; Celia C LaBranche; Sherry A Stanfield-Oakley; David C Montefiori; Guido Ferrari; Qizhi Yao
Journal:  Vaccines (Basel)       Date:  2020-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.